These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20811558)

  • 1. Surgical options for drug-refractory overactive bladder patients.
    Starkman JS; Smith CP; Staskin DR
    Rev Urol; 2010; 12(2-3):e97-e110. PubMed ID: 20811558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the management of overactive bladder.
    Fontaine C; Papworth E; Pascoe J; Hashim H
    Ther Adv Urol; 2021; 13():17562872211039034. PubMed ID: 34484427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
    Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The new era in the pharmacological treatment of overactive bladder (OAB): mirabegron--a new selective beta3agonist].
    Rechberger T; Kulik-Rechberger B; Miotła P; Wróbel A
    Ginekol Pol; 2014 Mar; 85(3):214-9. PubMed ID: 24783434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of refractory overactive bladder.
    Chen LC; Kuo HC
    Low Urin Tract Symptoms; 2019 Sep; 11(4):177-181. PubMed ID: 30900373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory overactive bladder: Beyond oral anticholinergic therapy.
    Glinski RW; Siegel S
    Indian J Urol; 2007 Apr; 23(2):166-73. PubMed ID: 19675795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation enterocystoplasty in overactive bladder: is there still a role?
    Reyblat P; Ginsberg DA
    Curr Urol Rep; 2010 Nov; 11(6):432-9. PubMed ID: 20734172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic and clinical aspects of antimuscarinic agents used to treat overactive bladder.
    Yamada S; Ito Y; Nishijima S; Kadekawa K; Sugaya K
    Pharmacol Ther; 2018 Sep; 189():130-148. PubMed ID: 29709423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatments for overactive bladder: focus on pharmacotherapy.
    Geoffrion R;
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1092-1101. PubMed ID: 23231848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of overactive bladder in women].
    Peyronnet B; Rigole H; Damphousse M; Manunta A
    Prog Urol; 2015 Nov; 25(14):877-83. PubMed ID: 26169251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonantimuscarinic treatment for overactive bladder: a systematic review.
    Olivera CK; Meriwether K; El-Nashar S; Grimes CL; Chen CC; Orejuela F; Antosh D; Gleason J; Kim-Fine S; Wheeler T; McFadden B; Balk EM; Murphy M;
    Am J Obstet Gynecol; 2016 Jul; 215(1):34-57. PubMed ID: 26851599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
    Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
    Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of refractory overactive bladder.
    Giarenis I; Cardozo L
    Minerva Ginecol; 2013 Feb; 65(1):41-52. PubMed ID: 23412019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The medical management of refractory overactive bladder.
    Robinson D; Giarenis I; Cardozo L
    Maturitas; 2013 Apr; 74(4):386-90. PubMed ID: 23395402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex.
    Chapple CR; Mironska E; Wagg A; Milsom I; Diaz DC; Koelbl H; Pushkar D; Tubaro A; De Ridder D; Chartier-Kastler E; Phillips LD
    Eur Urol Focus; 2020 May; 6(3):522-530. PubMed ID: 31623981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overactive Bladder.
    White N; Iglesia CB
    Obstet Gynecol Clin North Am; 2016 Mar; 43(1):59-68. PubMed ID: 26880508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actual treatment of overactive bladder and urge urinary incontinence.
    Cornu JN
    Minerva Urol Nefrol; 2013 Mar; 65(1):21-35. PubMed ID: 23538308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overactive bladder in the elderly: a guide to pharmacological management.
    Staskin DR
    Drugs Aging; 2005; 22(12):1013-28. PubMed ID: 16363885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolterodine extended release in the treatment of male OAB/storage LUTS: a systematic review.
    Gacci M; Novara G; De Nunzio C; Tubaro A; Schiavina R; Brunocilla E; Sebastianelli A; Salvi M; Oelke M; Gravas S; Carini M; Serni S
    BMC Urol; 2014 Oct; 14():84. PubMed ID: 25348235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.